
Radiation therapy (RT) to recurrence sites may not have an effect on oncologic outcomes in patients with muscle invasive bladder cancer (MIBC) who experience local recurrence or pelvic lymph node metastases after radical cystectomy (RC), according to new research presented at the 2024 American Urological Association Annual Meeting.
Patients with MIBC often experience local recurrence or pelvic lymph node metastases after RC. While chemotherapy and immunotherapy treatment options are often utilized in this setting, the effects of RT to recurrence sites are not fully understood.
Researchers conducted a multi-institutional, retrospective study of 950 patients with MIBC who underwent RC. Of these patients, 106 experienced local recurrence or pelvic lymph node metastases without distant metastases. The subsequent analysis was divided into 2 patient groups: those who were treated with RT to the recurrence sites and those who were not.